Opinion
Video
Author(s):
The panel reviews data from the SunRISe-1 trial investigating TAR-200 and offers its impressions on the efficacy and safety findings.
NMIBC Clinical Forums highlight novel therapies and treatment strategies
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
FDA approval sought for Anktiva in papillary NMIBC
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
The importance of federal funding in cancer research: A call to action
FDA updates in urology: March 2025